Abstract

Abstract The R47H variant of the Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) is a risk factor for Alzheimer’s disease in humans and leads to lower bone mass accrual in female but not male 12-month-old mice. To determine whether, as with aging, gonadectomy results in sex-specific musculoskeletal effects, gonad removal or SHAM surgery were performed in 4-month-old TREM2R47H/+ mice and wild type (WT) male and female littermates (n = 10-12/group), with sexes analyzed separately. Body weight was lower in males, but higher in females after gonadectomy, independently of their genotype. Gonadectomy also lead to decreased BMD in males at all sites and in whole body (total) and spine in female mice for both genotypes. Total and femur BMD was lower in gonadectomized male mice 6-weeks post-surgery, independently of the genotype. On the other hand, BMD was only lower in ovariectomized WT but not TREM2R47H/+ mice in all sites measured at this time point. Bone formation and resorption markers levels were not affected by orchiectomy, whereas CTX was higher 3 weeks after surgery and P1NP showed a tendency towards lower values at the 6 weeks timepoint only in ovariectomized WT mice. μCT analyses showed no differences resulting from gonadectomy in structural parameters in femoral cortical bone for either sex, but lower tissue mineral density in males of either genotype 6 weeks post-surgery. Nevertheless, biomechanical properties were overall lower in gonadectomized males of either genotype, and only for WT ovariectomized mice. Distal femur cancellous bone structure was also affected by gonadectomy in a genotype- and sex-dependent manner, with genotype-independent changes in males, and only in WT female mice. Thus, expression of the TREM2 R47H variant minimally alters the impact of gonadectomy in the musculoskeletal system in males, whereas it partially ameliorates the consequences of ovariectomy in female mice.